Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

Clinical trial NCT04979780 · COMPLETED

Trial details

NCT number: NCT04979780
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Treatment of Venous Thromboembolism in Cancer Patients Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients

Start date: 2021-07-20
Primary completion: 2022-03-31
Enrollment: 3708

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.